ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays Concepts Of New Grants Totaling $1.4 Million Year

February 18, 1983

Support Available For Studies Abroad

August 12, 1983

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

Possible Government Shutdown Looms Over Biomedical Research Funding Once More

September 23, 2011

In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research

May 17, 1991

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995